Literature DB >> 3101014

Relationship of fetal hemoglobin and oxygen content to lactate concentration in Rh isoimmunized pregnancies.

P W Soothill, K H Nicolaides, C H Rodeck, W H Clewell, J Lindridge.   

Abstract

Fetal blood samples were obtained fetoscopically from 32 Rh isoimmunized pregnancies at 18-32 weeks' gestation, and the hemoglobin concentration, plasma lactate concentration, and oxygen content were measured. When the hemoglobin concentration was more than 8 g/dL, the umbilical arterial and venous lactate concentrations were equal. Abnormal elevations of lactate were found in the umbilical artery at hemoglobin concentrations below 8 g/dL (oxygen content 2 mmol/L) and in the umbilical vein at hemoglobin concentrations below 4 g/dL (oxygen content 2 mmol/L); the arterial lactate values were higher than the venous. These results show that lactate is produced by the human fetus stressed by anemic hypoxia and suggest that compensatory cardiovascular mechanisms are unable to maintain adequate oxygenation to all tissues when the umbilical venous oxygen content falls below 2 mmol/L.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3101014

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

Review 1.  Causes and consequences of fetal acidosis.

Authors:  C S Bobrow; P W Soothill
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

2.  Atrial natriuretic factor in hydrops fetalis caused by Rh isoimmunisation.

Authors:  F R Moya; P A Grannum; L Riddick; J A Robert; J Pinheiro
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

3.  Prenatal asphyxia, hyperlacticaemia, hypoglycaemia, and erythroblastosis in growth retarded fetuses.

Authors:  P W Soothill; K H Nicolaides; S Campbell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-25

Review 4.  The fetal brain sparing response to hypoxia: physiological mechanisms.

Authors:  Dino A Giussani
Journal:  J Physiol       Date:  2016-01-06       Impact factor: 5.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.